login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AVANTIS INTERNATIONAL EQUITY (AVDE) Stock News
USA
-
NYSE Arca
- NYSEARCA:AVDE -
US0250727031
-
ETF
81.1
USD
+0.47 (+0.58%)
Last: 12/3/2025, 8:10:00 PM
Overview
Stock Chart
Technical Analysis
News
AVDE Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Stocktwits
- Mentions:
NVO
PID
Novo Nordisk Reportedly Slashes Workforce At Its US Wegovy Manufacturing Plant
3 months ago - By: Stocktwits
- Mentions:
NVO
PID
Novo Nordisk To Reportedly Cut Yearly Bonus For Denmark Employees: Retail Expects Stock To Hit $80 By Year-End
4 months ago - By: Stocktwits
- Mentions:
BUD
JSTC
BAC
SBUX
Budweiser Maker’s Stock Gets Crushed After Q2 Gloom — Retail Traders Feel 'Drop Is A Bit Unjustified'
6 months ago - By: Stocktwits
- Mentions:
NVO
APIE
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies
6 months ago - By: Stocktwits
- Mentions:
NVO
APIE
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking
6 months ago - By: Stocktwits
- Mentions:
NVO
APIE
AAPL
NVDA
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels
6 months ago - By: Stocktwits
- Mentions:
TM
FVD
Toyota Industries Likely To Accept $42B Takeover Bid From Toyota Motor And Group Companies, Says Report: Retail’s Undecided
6 months ago - By: Stocktwits
- Mentions:
TM
FVD
Toyota Records Fourth Straight Month Of Sales Jump In April: But Retail’s Not Yet Convinced
7 months ago - By: Stocktwits
- Mentions:
NVO
APIE
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish
7 months ago - By: Stocktwits
- Mentions:
NVO
APIE
WBA
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes
7 months ago - By: Stocktwits
- Mentions:
BUD
JSTC
Budweiser Maker AB InBev Plans $300M Investment To Expand US Production: Retail Turns Bullish
7 months ago - By: Stocktwits
- Mentions:
TM
FVD
TSLA
Toyota Expects 21% Profit Decline In FY26: Retail’s In Wait-And-Watch Mode
7 months ago - By: Stocktwits
- Mentions:
NVO
APIE
Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated
7 months ago - By: Benzinga
- Mentions:
UBS
IDVZ
Why Is UBS Stock Trading Lower On Wednesday?
7 months ago - By: Stocktwits
- Mentions:
NVO
APIE
LLY
HON
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia
7 months ago - By: Stocktwits
- Mentions:
NVO
APIE
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
8 months ago - By: Stocktwits
- Mentions:
GMAB
FBT
Genmab Stock Rises On Strong Darzalex Sales In Q1: Retail Remains Extremely Bullish
8 months ago - By: Stocktwits
- Mentions:
NVO
APIE
PFE
AAPL
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved
8 months ago - By: Stocktwits
- Mentions:
NVO
APIE
LLY
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish
8 months ago - By: Stocktwits
- Mentions:
NVO
MS
BAC
Novo Nordisk Stock Slips After BofA, Morgan Stanley Slash Price Targets – But Retail Goes Contrarian
8 months ago - By: Stocktwits
- Mentions:
NVO
APIE
Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves
10 months ago - By: Stocktwits
- Mentions:
SONY
APIE
SNE
Sony Stock Surges After Q3 Earnings Beat, Raised Outlook: Retail’s Not Convinced
10 months ago - By: Benzinga
- Mentions:
AVIV
SONY
SNE
Sony Beats Q3 Earnings Expectations, PS5 And Streaming Revenues Growth Prompts Outlook Raise
10 months ago - By: Stocktwits
- Mentions:
TM
FVD
APIE
Toyota Downgraded After Second Straight Profit Drop, But Stock Climbs As Annual Outlook Improves: Retail Stays Optimistic
Please enable JavaScript to continue using this application.